-
Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20150801
-
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120801
-
Novel and emerging drugs for rarer chronic lymphoid leukaemias.
Current cancer drug targets 20120601
-
Treatment of acute lymphoblastic leukemia in adults.
Critical reviews in oncology/hematology 20120101
-
Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.
Clinical Medicine Insights. Oncology 20120101
-
Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Current pharmaceutical design 20120101
-
Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.
PloS one 20120101
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Blood 20110929
-
Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder.
Hematology reports 20110831
-
In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia.
Blood 20110825
-
[Novel conventional therapies in onco-hemathology].
Bulletin du cancer 20110801
-
Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL.
[Rinsho ketsueki] The Japanese journal of clinical hematology 20110601
-
Educational paper. The development of new therapies for pediatric oncology.
European journal of pediatrics 20110501
-
Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
European journal of nuclear medicine and molecular imaging 20110401
-
New nucleoside analogs for patients with hematological malignancies.
Expert opinion on investigational drugs 20110301
-
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
ISRN hematology 20110101
-
Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.
Advances in hematology 20110101
-
An update on the management of peripheral T-cell lymphoma and emerging treatment options.
Journal of blood medicine 20110101
-
Rare tumors research in emerging countries.
Rare tumors 20100930
-
Towards the development of a rapid, portable, surface enhanced Raman spectroscopy based cleaning verification system for the drug nelarabine.
The Journal of pharmacy and pharmacology 20100901
-
Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma.
British journal of haematology 20100801
-
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
American journal of hematology 20100801
-
New trends in nucleoside biotechnology.
Acta naturae 20100701
-
A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells.
Oncology reports 20100201
-
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
BMC health services research 20100101
-
Use of clofarabine for acute childhood leukemia.
Biologics : targets & therapy 20100101
-
Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis?
Journal of transplantation 20100101
-
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
Molecular cancer 20100101
-
Nelarabine in the treatment of refractory T-cell malignancies.
Clinical Medicine Insights. Oncology 20100101
-
Application of new drugs in chronic lymphocytic leukemia.
Mediterranean journal of hematology and infectious diseases 20100101
-
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
Blood 20091210
-
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
Hematology/oncology clinics of North America 20091001
-
Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature.
Leukemia research 20090701
-
Novel therapies for relapsed acute lymphoblastic leukemia.
Current hematologic malignancy reports 20090701
-
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
British journal of cancer 20090616
-
Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Molecules (Basel, Switzerland) 20090323
-
Nelarabine: new drug. T-lymphoblastic leukaemia/lymphoma: more evaluation needed.
Prescrire international 20090201
-
[Severe liver injury following nelarabine chemotherapy for T-cell lymphoblastic lymphoma].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20090101
-
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Drug design, development and therapy 20090101
-
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia.
OncoTargets and therapy 20090101
-
Novel purine nucleoside analogues for hematological malignancies.
Recent patents on anti-cancer drug discovery 20080601
-
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
The oncologist 20080601
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20080501
-
Beyond the guidelines in the treatment of peripheral T-cell lymphoma: new drug development.
Journal of the National Comprehensive Cancer Network : JNCCN 20080401
-
Treating refractory leukemias in childhood, role of clofarabine.
Therapeutics and clinical risk management 20080401
-
Phase I trial of nelarabine in indolent leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
-
Nelarabine.
Drugs 20080101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20080101
-
Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy.
Current medicinal chemistry 20080101
-
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Seminars in oncology 20071201
-
Clinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies.
Seminars in oncology 20071201
-
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Therapeutics and clinical risk management 20071201
-
Nelarabine activity in acute biphenotypic leukemia.
Leukemia research 20071101
-
Nelarabine: a novel purine antimetabolite antineoplastic agent.
Clinical therapeutics 20070901
-
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Blood 20070615
-
Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
Cancer chemotherapy and pharmacology 20070501
-
In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
British journal of haematology 20070401
-
New drugs 07, part I.
Nursing 20070201
-
The long and winding road of the clinical development of Nelarabine.
Leukemia & lymphoma 20070101
-
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
Leukemia & lymphoma 20070101
-
Treatment of acute lymphoblastic leukaemia : a new era.
Drugs 20070101
-
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Expert opinion on investigational drugs 20061201
-
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
The Yale journal of biology and medicine 20061201
-
Clofarabine and nelarabine: two new purine nucleoside analogs.
Current opinion in oncology 20061101
-
Milestones in oncology: introducing a new section.
The oncologist 20061001
-
The legacy of great science: the work of Nobel Laureate Gertrude Elion lives on.
The oncologist 20061001
-
[Glaxo Smith Kline. A large oncology pipeline].
Medizinische Monatsschrift fur Pharmazeuten 20061001
-
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 20060915
-
Nelarabine in the treatment of refractory T-cell malignant diseases.
Expert opinion on pharmacotherapy 20060901
-
Nelarabine: a new purine analog in the treatment of hematologic malignancies.
Reviews on recent clinical trials 20060901
-
Nelarabine: efficacy in the treatment of clinical malignancies.
Future oncology (London, England) 20060801
-
Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.
Archives of neurology 20060701
-
Nelarabine use in leukemias.
Drugs of today (Barcelona, Spain : 1998) 20060701
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060601
-
Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents.
Mini reviews in medicinal chemistry 20060501
-
Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia.
The Medical letter on drugs and therapeutics 20060213
-
Nelarabine.
Nature reviews. Drug discovery 20060101
-
New drug to treat rare leukemia and lymphoma.
FDA consumer 20060101
-
New drugs: abatacept, sorafenib, and nelarabine.
Journal of the American Pharmacists Association : JAPhA 20060101
-
Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Current medicinal chemistry 20060101
-
Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Current cancer drug targets 20050901
-
Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias.
The Annals of pharmacotherapy 20050601
-
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
-
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
-
Purine nucleoside antimetabolites in development for the treatment of cancer.
Current opinion in investigational drugs (London, England : 2000) 20040601
-
New nucleoside analogs in the treatment of hematological disorders.
Acta poloniae pharmaceutica 20040101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20031101
-
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Cancer research 20020601
-
CD4-CD8-'Double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course.
The American journal of surgical pathology 20020201
-
Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
Leukemia 20011201
-
Nucleoside analogues in the treatment of haematological malignancies.
Expert opinion on pharmacotherapy 20010601
-
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415
-
6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
Antimicrobial agents and chemotherapy 19910501